AVEVA Group Still Expects Solid Cash Generation In Q3 - Quick Facts

AVEVA Group plc (AVV.L, AVEVF.PK), a provider of engineering data and design IT systems, issued an interim management statement for the period from October 1, 2013 to date.

Since its interim results announcement in November 2013, the company noted that it has not witnessed any noticeable shift in the trends reported at that time and overall the Group continued to perform well during the period. The Group said it maintained a strong balance sheet and continued to see solid cash generation in the third quarter.

While the Americas region continued to feel the effect of soft market conditions in Latin America, AVEVA has seen further good progress in the U.S. and Canada, thereby building on the success achieved in the first half. The Asia Pacific region still improves at a steady pace, with continued strength in South Korea more than offsetting the generally weaker economic conditions in China. The EMEA region has been affected in the current fiscal year, impacted by the lower than expected revenue growth in Enterprise Solutions, and some continued weakness in Russia and the Middle East.

During the first half of the fiscal year, the Group revenue benefitted, on a reported basis, from sterling weakening against the Euro and Korean Won, partially offset by a strengthening against the Japanese Yen. On the other hand, in the second half, sterling has strengthened significantly making a negative foreign exchange translation impact more likely for the year.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Cargill, Inc., a privately held food company, is recalling certain chocolate products containing recalled Jif peanut butter due to the potential for salmonella contamination, the U.S. Food and Drug Administration said. The recall involves 795, 8-ounce boxes of Wilbur brand products, such as Milk and Dark Chocolate Covered Peanut Butter Ritz Crackers, Peanut Butter Meltaways... The U.S. Food and Drug Administration approved Regeneron Pharmaceuticals, Inc.'s Dupixent (dupilumab) to treat eosinophilic esophagitis or EoE, a chronic immune disorder. It is the first FDA approval to treat EoE in adults and pediatric patients 12 years and older weighing at least 40 kilograms. Food products maker J. M. Smucker Co. has recalled select Jif peanut butter products sold in the United States due to potential Salmonella contamination, the U.S. Food and Drug Administration said. The recall involves various creamy, crunchy, natural, no added sugar, and reduced fat peanut butter, among others with lot codes 1274425 - 2140425.
Follow RTT